SCHV vs XLV
Schwab US Large-Cap Value ETF vs Health Care Select Sector SPDR Fund
- • SCHV has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • SCHV pays a higher dividend yield (1.85%).
Side-by-side metrics
| Metric | SCHV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.85% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $15.17B | $37.88B |
YTD return | 11.49% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.82 | 0.58 |
P/E ratio | 21.96 | 26.68 |
Last price | $32.47 | $144.72 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHV top holdings
| BRK-B | Berkshire Hathaway Inc Class B | 2.97% |
| JPM | JPMorgan Chase & Co | 2.84% |
| XOM | Exxon Mobil Corp | 2.20% |
| MU | Micron Technology Inc | 1.99% |
| WMT | Walmart Inc | 1.91% |
| JNJ | Johnson & Johnson | 1.86% |
| INTC | Intel Corp | 1.51% |
| CAT | Caterpillar Inc | 1.28% |
| ABBV | AbbVie Inc | 1.23% |
| CVX | Chevron Corp | 1.23% |
XLV top holdings
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost. Managed by Schwab, the fund carries $15.2B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.85%. Its largest holding is Berkshire Hathaway Inc Class B (BRK-B), which represents 3.0% of the portfolio. Real Estate is the fund's largest sector exposure at 4.1%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.